• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number WCD 4000
Device Problem Device Sensing Problem (2917)
Patient Problems Bradycardia (1751); Ventricular Fibrillation (2130); Asystole (4442)
Event Date 12/23/2021
Event Type  Death  
Event Description
A us distributor contacted zoll to report that a patient passed away in the hospital while wearing the lifevest on (b)(6) 2021.Per clinical review of the continuous ecg recording, the device was started up at 18:19:26 on (b)(6) 2021.Asystole was detected at 00:27:25.Ecg shows idioventricular rhythm at 70 bpm degrading to vf with low amplitude cardiac signal, motion artifact, and electrode lead fall off.Device was shutdown at 00:29:51 on (b)(6) 2021.Per continuous holter recording, the patient's rhythm was sinus bradycardia at 40 bpm with hb.Rhythm transitions to an idioventricular rhythm from 90-80 bpm with pvc's, low amplitude cardiac signal, cpr motion artifact, and electrode lead fall off.Rhythm then degrades to vf with low amplitude cardiac signal, motion artifact, and electrode lead fall off.The rhythm then degrades to asystole with motion artifact and electrode lead fall off from approximately 23:58:47 until the device was shutdown at 00:29:51 on (b)(6) 2021.Motion artifact and electrode lead fall off prevented the lifevest from treating while the patient's rhythm was in vf.
 
Manufacturer Narrative
Device evaluation of the monitor and electrode belt has been completed.The evaluation included review of downloaded software flag files on the day of the event and incoming functional testing.During the incoming functional testing, a 1 hz simulated normal sinus rhythm signal was applied to the ecg electrodes, followed by a 5 hz simulated treatable arrhythmia signal which verified proper performance of the detection algorithm.During the transition to the 5 hz signal, the device was confirmed to properly enter into a treatment sequence which includes a verification of the tactile vibration alarm, audio messaging, and siren alarms, as well as a test of the pulse delivery circuitry.The pulse delivery circuitry test verified proper charging of the high voltage capacitors and proper delivery of five full energy 150j biphasic pulses.The functional testing confirmed proper response button functionality, ecg acquisition, detection algorithm performance, and pulse delivery functionality.There is no indication of a product malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFEVEST WCD 4000 SYSTEM
Type of Device
WEARABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ZOLL MANUFACTURING CORPORATION
121 gamma drive
pittsburgh PA 15238 3495
Manufacturer (Section G)
ZOLL MANUFACTURING CORPORATION
121 gamma drive
pittsburgh PA 15238 3495
Manufacturer Contact
steven kyle
121 gamma drive
pittsburgh, PA 15238-3495
4129683333
MDR Report Key13549851
MDR Text Key285755232
Report Number3008642652-2022-01778
Device Sequence Number1
Product Code MVK
UDI-Device Identifier00855778005005
UDI-Public00855778005005
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Other
Type of Report Initial
Report Date 02/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberWCD 4000
Device Catalogue Number10A0988
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/21/2022
Initial Date Manufacturer Received 02/11/2022
Initial Date FDA Received02/17/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/02/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Death;
-
-